|
ABOUT COMPANY
Taysha Gene Therapies, Inc., a gene therapy company, focuses on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company is headquartered in Dallas, Texas.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 448221000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -3.808
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: None
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|